Description
Arglabin is a potent anti-inflammatory and anticancer agent. It also acts as a Farnesyltransferase inhibitor and antiatherogenic compound. Prevents the accumulation of lipid containing plaques in arteries. In addition, Arglabin also acts as a NF-κB inhibitor and inflammasome inhibitor.
Arglabin is a potent anti-inflammatory and anticancer agent. It also acts as a Farnesyltransferase inhibitor and antiatherogenic compound. Prevents the accumulation of lipid containing plaques in arteries. In addition, Arglabin also acts as a NF-κB inhibitor and inflammasome inhibitor.
Alternate Name/Synonyms: Arglabine
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 84692-91-1
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₅H₁₈O₃
Molecular Weight: 246.3
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent anti-inflammatory, anticancer agent and fatnesyltransferase inhibitor
MDL Number: N/A
PubChem CID: 636760
SMILES: CC1=CCC23C1C4C(CCC2(O3)C)C(=C)C(=O)O4
InChi: InChI=1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11-,12-,14-,15+/m0/s1
InChi Key: UVJYAKBJSGRTHA-ZCRGAIPPSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |